PVLA
insider transactionsPALVELLA THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 3 different insiders made open-market purchases in the last 365 days, totalling $1.8M.
Net shares · 365d
+21.3K
42.8K buy · 21.5K sell
Net value · 365d
-$442.2K
$1.8M in · $2.3M out
Sentiment · 365d
Net buying
45% buying · 55% selling
Open-market trades · 365d
20
42.8K buy · 21.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$14.4K
503 sh · $28.73
Own +1%
-
Buy·P
Director
$985.5K
35.4K sh · $27.80
Own +89%
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +25%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +25%
-
Sell·S
Chief Operating Officer · 10b5-1
$5.4K
48 sh · $111.90
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$99.2K
891 sh · $111.30
Own -95%
-
Sell·S
Chief Operating Officer · 10b5-1
$371.1K
3.4K sh · $110.35
Own -78%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +20%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +20%
-
Sell·S
Chief Operating Officer · 10b5-1
$13.0K
100 sh · $130.33
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$82.5K
639 sh · $129.17
Own -86%
-
Sell·S
Chief Operating Officer · 10b5-1
$71.9K
561 sh · $128.23
Own -43%
-
Sell·S
Chief Operating Officer · 10b5-1
$190.7K
1.5K sh · $127.13
Own -54%
-
Sell·S
Chief Operating Officer · 10b5-1
$189.2K
1.5K sh · $125.96
Own -35%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Grant·A
Director
$0
6.0K sh
Own New
-
Buy·P
Director
$50.0K
445 sh · $112.30
Own +0%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +17%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +17%
-
Sell·S
Chief Operating Officer · 10b5-1
$36.2K
304 sh · $119.08
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$204.8K
1.7K sh · $118.37
Own -85%
-
Sell·S
Chief Operating Officer · 10b5-1
$266.6K
2.3K sh · $117.56
Own -53%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Grant·A
Todd C Davis KEY
Chief Executive Officer
$0
50.1K sh
Own New
-
Grant·A
Todd C Davis KEY
Chief Executive Officer
$0
10.5K sh
Own +6%
-
Buy·P
Director
$500.0K
4.0K sh · $125.00
Own +2%
-
Buy·P
Director
$300.0K
2.4K sh · $125.00
Own +5%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +14%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +14%
-
Sell·S
Chief Operating Officer · 10b5-1
$102.0K
1.3K sh · $79.97
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$239.5K
3.0K sh · $79.16
Own -70%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Other·F
Todd C Davis KEY
Chief Executive Officer
$515.6K
2.8K sh · $183.83
Own -1%
-
Other·F
Todd C Davis KEY
Chief Executive Officer
$782.2K
4.3K sh · $183.83
Own -2%
-
Other·F
Todd C Davis KEY
Chief Executive Officer
$374.8K
2.0K sh · $183.83
Own -1%
-
Other·F
Todd C Davis KEY
Chief Executive Officer
$2.9M
15.6K sh · $183.83
Own -7%
-
Grant·A
Todd C Davis KEY
Chief Executive Officer
$0
39.6K sh
Own +23%
-
Other·F
Todd C Davis KEY
Chief Executive Officer
$1.5M
8.2K sh · $183.83
Own -4%
-
Grant·A
Todd C Davis KEY
Chief Executive Officer
$0
20.8K sh
Own +13%
-
Grant·A
Chief Scientific Officer
$0
64.3K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
38.5K sh
Own New
-
Grant·A
Wes Kaupinen KEY
President and CEO
$0
124.6K sh
Own New
-
Grant·A
Chief Operating Officer
$0
49.0K sh
Own New
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +12%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +12%
-
Sell·S
Chief Operating Officer · 10b5-1
$367.2K
3.7K sh · $97.94
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$52.8K
553 sh · $95.49
Own -13%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Grant·A
Director
$0
19.1K sh
Own +92%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Todd C Davis | Buy P | 503 | $14.4K |
| Jun 11, 2026 | Todd C Davis | Buy P | 35.4K | $985.5K |
| Jun 10, 2026 | Tadd S. Wessel | Grant A | 3.0K | $0 |
| Jun 10, 2026 | Christopher P Kiritsy | Grant A | 3.0K | $0 |
| Jun 10, 2026 | George M Jenkins | Grant A | 3.0K | $0 |
| Jun 10, 2026 | Elaine J Heron | Grant A | 3.0K | $0 |
| Jun 10, 2026 | John Doux | Grant A | 3.0K | $0 |
| Jun 10, 2026 | Todd C Davis | Grant A | 3.0K | $0 |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| May 20, 2026 | Kathleen Goin 10b5-1 | Sell S | 48 | $5.4K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Sell S | 891 | $99.2K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Sell S | 3.4K | $371.1K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 100 | $13.0K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 639 | $82.5K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 561 | $71.9K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 1.5K | $190.7K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 1.5K | $189.2K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Apr 13, 2026 | John Doux | Grant A | 6.0K | $0 |
| Mar 30, 2026 | George M Jenkins | Buy P | 445 | $50.0K |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Sell S | 304 | $36.2K |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Sell S | 1.7K | $204.8K |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Sell S | 2.3K | $266.6K |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| Mar 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Mar 2, 2026 | Todd C Davis KEY | Grant A | 50.1K | $0 |
| Mar 2, 2026 | Todd C Davis KEY | Grant A | 10.5K | $0 |
| Feb 27, 2026 | George M Jenkins | Buy P | 4.0K | $500.0K |
| Feb 27, 2026 | Elaine J Heron | Buy P | 2.4K | $300.0K |
| Feb 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| Feb 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| Feb 18, 2026 | Kathleen Goin 10b5-1 | Sell S | 1.3K | $102.0K |
| Feb 18, 2026 | Kathleen Goin 10b5-1 | Sell S | 3.0K | $239.5K |
| Feb 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| Feb 18, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Feb 15, 2026 | Todd C Davis KEY | Other F | 2.8K | $515.6K |
| Feb 15, 2026 | Todd C Davis KEY | Other F | 4.3K | $782.2K |
| Feb 15, 2026 | Todd C Davis KEY | Other F | 2.0K | $374.8K |
| Feb 14, 2026 | Todd C Davis KEY | Other F | 15.6K | $2.9M |
| Feb 14, 2026 | Todd C Davis KEY | Grant A | 39.6K | $0 |
| Feb 14, 2026 | Todd C Davis KEY | Other F | 8.2K | $1.5M |
| Feb 14, 2026 | Todd C Davis KEY | Grant A | 20.8K | $0 |
| Feb 5, 2026 | Jeffrey S Martini | Grant A | 64.3K | $0 |
| Feb 5, 2026 | Ashley Hartmann Kline | Grant A | 38.5K | $0 |
| Feb 5, 2026 | Wes Kaupinen KEY | Grant A | 124.6K | $0 |
| Feb 5, 2026 | Kathleen Goin | Grant A | 49.0K | $0 |
| Jan 21, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| Jan 21, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| Jan 21, 2026 | Kathleen Goin 10b5-1 | Sell S | 3.7K | $367.2K |
| Jan 21, 2026 | Kathleen Goin 10b5-1 | Sell S | 553 | $52.8K |
| Jan 21, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| Jan 21, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Jul 2, 2025 | Todd C Davis | Grant A | 19.1K | $0 |
About PVLA insider trading
This page tracks insider transactions for PALVELLA THERAPEUTICS, INC. (PVLA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.